VCYT FY 2025 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena

VCYTVeracyte, Inc.

$3B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$517M+16.0% YoY

Gross Profit

$360M69.6% margin

Operating Income

$74M14.3% margin

Net Income

$66M12.8% margin

EPS (Diluted)

$0.82

Cash Flow

Operating Cash Flow

$136M

Free Cash Flow

$127M

Stock-Based Comp.

$44M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$96M

Stockholders' Equity

$1.3B

Cash & Equivalents

$363M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$517M	$446M	+16.0%
Gross Profit	$360M	$298M	+20.8%
Operating Income	$74M	$16M	+359.4%
Net Income	$66M	$24M	+174.9%